Study drug for PTSD symptoms in Veterans
Part of Mental health clinical trials.
This trial tests a study medicine that blocks the effects of cortisol (a stress hormone) to reduce PTSD symptoms in Veterans. It’s meant for people with ongoing PTSD symptoms and stable treatments, and it closely checks safety because the medicine can affect sleep, mood, and heart rhythm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a U.S. military Veteran
- You can read and understand English and agree to sign consent forms
- Your PTSD symptoms are high on a PTSD checklist test (CAPS-5 score 23 or higher)
- You plan to use two reliable birth control methods (if you can become pregnant), one must be a barrier method
- If you take PTSD medicines (SSRI/SNRI), sleep medicine (trazodone), pain opioids, or therapy, your dose/treatment must be stable for the required time
- You can meet safety rules, including not having certain recent substance use, mental health diagnoses, major recent trauma, or untreated sleep apnea
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a medication that blocks a brain chemical called orexin can help people with PTSD sleep better and reduce fear. You must have chronic PTSD, trouble sleeping, and be a U.S. military veteran.
This trial tests an experimental medicine, HB-1, as a potential treatment for PTSD. It is a 8-week study to see if the medicine is safe and if it reduces PTSD symptoms. You must have a stable medication routine and be willing to take the study pill daily.
This study tests whether stimulant medications can help treat PTSD symptoms. Researchers want to see if these medications are safe and effective for people with PTSD.
This study tests a counseling approach called Cognitive Processing Therapy (CPT) with added memory support tools. It may help reduce PTSD symptoms while also supporting day-to-day memory challenges common in PTSD.
This Phase 3 study tests whether low-dose clonidine can reduce PTSD symptoms and especially nightmares in U.S. veterans. You’d be screened for PTSD severity and current treatments, then asked to visit the clinic as scheduled to see if the treatment helps.
This trial tests a new oral medication, PT150, to see if it helps reduce PTSD symptoms in veterans. You must have had PTSD for at least 3 months and not be taking certain other medications.
Hear when a new PTSD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.